Charkit makes a promotion

Jay Lang becomes executive vice president

Charkit Chemical Corporation has promoted Jay Lang to executive vice president of the company.

Lang has been with the Connecticut, US-based firm nearly 17 years and according to president, Charles Hinnant, in that time he has made a ‘notable contribution’ to the firm’s growth.

‘In his previous role as vice president at Charkit, he was a pivotal professional in making many of the decisions that have led to the substantial inroads we have made as a provider of innovative personal care ingredients, most recently demonstrated by our acquisition of ISI,’ Hennant said.

In his new role, Lang will play an active part in seeking new acquisitions. He will also direct new sales efforts and grow Charkit’s team of personal care experts.

Founded in 1982, Charkit Chemical Corporation offers a range of products to the imaging, personal care, food, flavour and fragrance, water treatment, metal treatment and pharmaceutical industries as well as to producers of fine and specialist chemicals.

You may also like

Ingredients

LBB Specialties enters US distribution deal with German Meggle

Through US subsidiaries LBB will distribute Meggle Excipients & Technology’s excipient products to companies in the American pharmaceutical and nutraceutical industries
Ingredients

Global cerium market estimated to grow strongly by 2021

Caprylic acid is used as raw material in manufacturing of surfactants, disinfectants, as an oil base and as emulsifiers in emulsion polymerisation.
Ingredients

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients
Manufacturing

NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies
Ingredients

Pioneering AAV approach unlocks cause of rheumatoid arthritis pain

Karolinska Institute researchers use AAV products to uncover neural mechanisms behind rheumatoid arthritis pain
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing

As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
Subscribe now